Reply to: Calcium channel blockers therapy and the risk of prostate cancer death

Dear Editor, We are very pleased to answer the comments on our manuscript “Antihypertensive drugs and prostate cancer survival after radical prostatectomy in Finland – a nationwide cohort study.”1 Lai et al. wonder whether androgens would be a potent confounding subject for prostate cancer (PCa) diagnosis. At first, it is important to consider that risk factors for PCa diagnosis might be different compared to risk factors for PCa death, as may...